NCT07113613View on ClinicalTrials.gov

Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy

PHASE2RecruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2031

Conditions

Breast Cancer

Interventions

RADIATION

Exemption from additional radiotherapy on the tumor bed after surgery

For patients who met the inclusion criteria and were enrolled, postoperative tumor bed boost radiotherapy was waived, and only whole breast and/or regional lymph node irradiation was administered.

Trial Locations (1)

210029

RECRUITING

The First Affiliated with Nanjing Medical University (Jiangsu Province People's Hospital), Nanjing

All Listed Sponsors

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER